Dorsey Wright & Associates’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-240
Closed -$10K 353
2020
Q2
$10K Buy
+240
New +$10K ﹤0.01% 257